10285-07-1 (石松胺,LYCOPSAMINE)

石松胺;番茄红素;双咪唑 [or 2-正丙基-4-甲基-6-(1'-甲基苯骈咪唑-2-基)苯并咪唑];

(+)-Lycopsamine;[(7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate;Butanoic acid,2,3-dihydroxy-2-(1-methylethyl)-,[(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S;Butanoic acid,2,3-dihydroxy-2-(1-methylethyl)-,[(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S)-;LYCOPSAMINE;3,4-Didehydroretinol hexadecanoate;3-Dehydroretinol palmitate;3-Dehydroretinyl palmitate;dehydroretinyl palmitate;Retinol,3,4-didehydro-,hexadecanoate;Retinylpalmitat;retronecine-O(9)-(-)-viridifloryl ester;Retronecine 9-(−)-viridiflorate;Lycopsamin;Ccris 9199;Ccirs 9199;(2S,3S)-2,3-Dihydroxy-2-isopropylbutanoic acid [(7R)-7β-hydroxy-5,6,7,7aα-tetrahydro-3H-pyrrolizine-1-yl]methyl ester;(2S,3S)-2,3-Dihydroxy-2-isopropylbutanoic acid [(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizine-7-yl]methyl ester;(1R-(1alpha,7(2S*,3S*),7Abeta))-(2,3,5,7A-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl 2,3-dihydroxy-2-(1-methylethyl)butanoate;Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, ((1R,7ar)-2,3,5,7A-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (2S,3S)-;Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7A-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (1R-(1alpha,7(2S*,3S*),7abeta))-;CHEBI:6598;MFCD09260181;UER4ET3OHI;1ST14171;RETRONECINE 9-((-)-VIRIDIFLORATE);BUTANOIC ACID, 2,3-DIHYDROXY-2-(1-METHYLETHYL)-, (2,3,5,7A-TETRAHYDRO-1-HYDROXY-1H-PYRROLIZIN-7-YL)METHYL ESTER, (1R-(1.ALPHA.,7(2S*,3S*),7A.BETA.))-;DTXCID9068033;Lycopsamine 100 microg/mL in Water;J-000819;SFVVQRJOGUKCEG-ZGFBFQLVSA-N;Q27107262;9-Viridiflorylretronecine;Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1R-[1?,7(2S*,3S*),7a?]]-; Lycopsamine (7CI,8CI); (+)-Lycopsamine; 3'-epi-Intermedine; Retronecine 9-((-)-viridiflorate);AKOS040752803;10285-07-1;NS00098507;CS-0089560;((1R,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl (2S,3S)-2,3-dihydroxy-2-isopropylbutanoate;HY-124916;DTXSID60145542;Lycopsamine, HPLC Grade;[(1R,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate;UNII-UER4ET3OHI;3'-EPI-INTERMEDINE;C15H25NO5;Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1R-[1a,7(2S*,3S*),7ass]]-; Lycopsamine (7CI,8CI); (+)-Lycopsamine; 3'-epi-Intermedine; Retronecine 9-((-)-viridiflorate);DA-55120;

MFCD09260181

SFVVQRJOGUKCEG-ZGFBFQLVSA-N

1S/C15H25NO5/c1-9(2)15(20,10(3)17)14(19)21-8-11-4-6-16-7-5-12(18)13(11)16/h4,9-10,12-13,17-18,20H,5-8H2,1-3H3/t10-,12+,13+,15-/m0/s1

O[C@@H]1CCN2CC=C(COC([C@@]([C@H](C)O)(C(C)C)O)=O)[C@@H]21